Therapy Areas: Respiratory
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
5 March 2026 - Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, announced on Wednesday that it has received Brea...
Novartis to build new radioligand therapy site in Texas
...
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
25 February 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has agreed to acquire 35Pharma Inc., a Canada-based clinical-stage biopharmaceutical company, ...
Epredia signs EU distribution deal with Mindpeak for AI pathology software
24 February 2026 - Precision cancer diagnostics specialist Epredia, a subsidiary of PHC Holdings Corporation (TSE:6523), and Mindpeak, a provider of AI solutions for clinical and research pathology, o...
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
...
CStone Pharmaceuticals' sugemalimab granted new indication by UK MHRA
23 February 2026 - Chinese biopharmaceutical company CStone Pharmaceuticals (HKEX:2616) announced on Sunday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a new ind...